药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dextromoramide
Bioallethrin
Gallopamil may increase the arrhythmogenic activities of Bioallethrin.
Dextromoramide
Hydroquinine
Gallopamil may increase the arrhythmogenic activities of Hydroquinine.
Dextromoramide
Ethacizine
Gallopamil may increase the arrhythmogenic activities of Ethacizine.
Dextromoramide
Tiracizine
Gallopamil may increase the arrhythmogenic activities of Tiracizine.
Dextromoramide
Spiradoline
Spiradoline may increase the arrhythmogenic activities of Gallopamil.
Dextromoramide
Tropisetron
Tropisetron may increase the arrhythmogenic activities of Gallopamil.
Dextromoramide
Fasudil
Fasudil may increase the arrhythmogenic activities of Gallopamil.
Dextromoramide
Sparteine
Sparteine may increase the arrhythmogenic activities of Gallopamil.
Dextromoramide
Xylometazoline
Xylometazoline may increase the arrhythmogenic activities of Gallopamil.
Dextromoramide
Lithium hydroxide
The risk or severity of adverse effects can be increased when Gallopamil is combined with Lithium hydroxide.
Dextromoramide
Lithium carbonate
The risk or severity of adverse effects can be increased when Gallopamil is combined with Lithium carbonate.
Dextromoramide
Lithium citrate
The risk or severity of adverse effects can be increased when Gallopamil is combined with Lithium citrate.
Dextromoramide
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Gallopamil.
Dextromoramide
Ivabradine
Gallopamil may increase the bradycardic activities of Ivabradine.
4-Methyl-2,5-dimethoxyamphetamine
Satralizumab
The serum concentration of Tazemetostat can be decreased when it is combined with Satralizumab.
4-Methyl-2,5-dimethoxyamphetamine
Abametapir
The serum concentration of Tazemetostat can be increased when it is combined with Abametapir.
4-Methyl-2,5-dimethoxyamphetamine
Darolutamide
The serum concentration of Tazemetostat can be increased when it is combined with Darolutamide.
4-Methyl-2,5-dimethoxyamphetamine
Cenobamate
The serum concentration of Tazemetostat can be decreased when it is combined with Cenobamate.
4-Methyl-2,5-dimethoxyamphetamine
Belantamab mafodotin
The serum concentration of Belantamab mafodotin can be increased when it is combined with Tazemetostat.
4-Methyl-2,5-dimethoxyamphetamine
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Tazemetostat.